PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma
Saved in:
Main Authors: | Michael B. Atkins, Suthee Rapisuwon, Arash Radfar, Kellie Gardner, Neil J. Shah, Geoffrey T. Gibney, Jacob Zaemes, Shelly Shand, David Swoboda, Vesna Petronic-Rosic, Michael J. Reilly, Waddah B. Al-Refaie |
---|---|
Format: | article |
Language: | EN |
Published: |
BMJ Publishing Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/da787bd08d4c48ef8ac5864ccea25a5d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Short-Facelift Approach in Temporal Artery Biopsy: Is It Safe?
by: Mario Faenza, et al.
Published: (2021) -
Psoriasis: epidemiology, natural history, and differential diagnosis
by: Basko-Plluska JL, et al.
Published: (2012) -
Skin biopsies in acute myeloid leukemia patients undergoing intensive chemotherapy are safe and effect patient management
by: Tamar Berger, et al.
Published: (2021) -
Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses
by: Siang-Boon Koh, et al.
Published: (2021) - An interdisciplinary journal of discontinuity, nonlinearity, and complexity